Nabumetone
NDC 87063-292, Nabumetone, tablet, from ASCLEMED USA INC..
- Product NDC
- 87063-292
- Status
- Listed
- Labeler
- ASCLEMED USA INC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078420
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/87063-292 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NABUMETONE750 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 87063-292-01 | 87063029201 | 100 TABLET in 1 BOTTLE (87063-292-01) |
| 87063-292-06 | 87063029206 | 6 TABLET in 1 BOTTLE (87063-292-06) |
| 87063-292-07 | 87063029207 | 7 TABLET in 1 BOTTLE (87063-292-07) |
| 87063-292-10 | 87063029210 | 10 TABLET in 1 BOTTLE (87063-292-10) |
| 87063-292-20 | 87063029220 | 20 TABLET in 1 BOTTLE (87063-292-20) |
| 87063-292-30 | 87063029230 | 30 TABLET in 1 BOTTLE (87063-292-30) |
| 87063-292-60 | 87063029260 | 60 TABLET in 1 BOTTLE (87063-292-60) |
| 87063-292-90 | 87063029290 | 90 TABLET in 1 BOTTLE (87063-292-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 87063-292 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/87063-292 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 87063-292. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.